Education
About Us
Working with TipRanks
Follow Us
P3 Health Partners (PIII)
NASDAQ:PIII
Total Valuation
P3 Health Partners has a market cap or net worth of $54.44M. The enterprise value is $234.73M.
Market Cap$54.44M
Enterprise Value$234.73M
Share Statistics
P3 Health Partners has 163.16M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding163.16M
Owned by Insiders60.09%
Owned by Instutions8.73%
Financial Efficiency
P3 Health Partners’s return on equity (ROE) is -3.97 and return on invested capital (ROIC) is -89.79%.
Return on Equity (ROE)-397.18%
Return on Assets (ROA)-38.50%
Return on Invested Capital (ROIC)-89.79%
Return on Capital Employed (ROCE)-111.73%
Revenue Per Employee$4,167,930.556
Profits Per Employee-$837,788.889
Employee Count360
Asset Turnover1.92
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of P3 Health Partners is -0.11. P3 Health Partners’s PEG ratio is >-0.01.
PE Ratio-0.11
PS Ratio0.02
PB Ratio0.43
Price to Fair Value0.43
Price to FCF-0.30
Price to Operating Cash Flow-0.30
PEG Ratio>-0.01
Income Statement
In the last 12 months, P3 Health Partners had revenue of $1.50B and earned -$301.60M in profits. Earnings per share was $0.00.
Revenue$1.50B
Gross Profit-$37.08M
Operating Income$0.00
Pretax Income-$305.99M
Net Income-$301.60M
EBITDA-346.10M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -$110.13M and capital expenditures $0.00, giving a free cash flow of -$110.13M billion.
Operating Cash Flow-$110.13M
Free Cash Flow-$110.13M
Free Cash Flow per Share-$0.67
Dividends & Yields
P3 Health Partners pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-337.30%
Earnings Yield-923.75%
Stock Price Statistics
Beta1.51
52-Week Price Change-58.52%
50-Day Moving Average9.34
200-Day Moving Average16.67
Relative Strength Index (RSI)57.91
Average Volume (3m)674.41K
Important Dates
P3 Health Partners upcoming earnings date is May 7, 2025, Before Open.
Last Earnings DateMar 27, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend Date―
Financial Position
P3 Health Partners as a current ratio of 0.37, with Debt / Equity ratio of 1.01
Current Ratio0.37
Quick Ratio0.37
Debt to Market Cap2.34
Net Debt to EBITDA-0.15
Interest Coverage Ratio14.46
Taxes
In the past 12 months, P3 Health Partners has paid -$4.39M in taxes.
Income Tax-$4.39M
Effective Tax Rate1.43%
Enterprise Valuation
P3 Health Partners EV to EBITDA ratio is -0.29, with an EV/FCF ratio of -0.64.
EV to Sales0.05
EV to EBITDA-0.29
EV to Free Cash Flow-0.64
EV to Operating Cash Flow-0.64
Balance Sheet
P3 Health Partners has $38.82M in cash and marketable securities with $76.34M in debt, giving a net cash position of $37.52M billion.
Cash & Marketable Securities$38.82M
Total Debt$76.34M
Net Cash$37.52M
Net Cash Per Share$0.23
Tangible Book Value Per Share-$2.93
Margins
Gross margin is 100.00%, with operating margin of -21.37%, and net profit margin of -20.10%.
Gross Margin100.00%
Operating Margin-21.37%
Pretax Margin-20.39%
Net Profit Margin-20.10%
EBITDA Margin-16.14%
EBIT Margin-21.87%
Analyst Forecast
The average price target for P3 Health Partners is $20.42, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$20.42
Price Target Upside127.14%
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast18.48%
EPS Growth Forecast-37.42%